TP53 and neoplasm: We investigated whether the abundance of the four T-cell subsets in tumor-rich regions was associated with established clinicopathological parameters, including gender, age, TP53 mutational status, Ki-67 (IHC) and p53 (IHC) protein levels (Supplementary Materials Table S6).